Meriwether Wealth & Planning’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.03M Sell
2,654
-25
-0.9% -$10K 0.47% 34
2026
Q2
$1.04M Sell
2,679
-183
-6% -$67.9K 0.51% 33
2026
Q1
$838K Buy
2,862
+916
+47% +$301K 0.46% 44
2025
Q4
$682K Sell
1,946
-23
-1% -$7.77K 0.38% 51
2025
Q3
$636K Sell
1,969
-158
-7% -$49.1K 0.37% 53
2025
Q2
$827K Sell
2,127
-17
-0.8% -$6.84K 0.52% 40
2025
Q1
$933K Buy
2,144
+540
+34% +$217K 0.61% 36
2024
Q4
$592K Buy
+1,604
New +$671K 0.42% 52

Other funds holding ELV

Meriwether Wealth & Planning's ELV Position: Q3 2026 in Review

Meriwether Wealth & Planning reduced its Elevance Health (ELV) stake by 0.93% in Q3 2026, selling an estimated $10K and leaving 2,654 shares worth $1.03M. The position accounts for 0.47% of the portfolio, ranked #34.

Meriwether Wealth & Planning first reported a position in ELV in Q4 2024 and has held it in 8 quarters since. The position peaked at $1.04M in Q2 2026. 285 funds tracked by Wall St. Rank hold ELV as of Q3 2026.

  • Meriwether Wealth & Planning held 2,654 shares of Elevance Health worth $1.03M as of Q3 2026.
  • Meriwether Wealth & Planning sold 25 Elevance Health shares in Q3 2026, an estimated $10K.
  • Elevance Health made up 0.47% of Meriwether Wealth & Planning's portfolio in Q3 2026, its #34 holding.
  • Meriwether Wealth & Planning first reported a position in Elevance Health in Q4 2024 and has held it in 8 quarters since.
  • Meriwether Wealth & Planning's Elevance Health position peaked at $1.04M in Q2 2026.
  • 285 funds tracked by Wall St. Rank held Elevance Health as of Q3 2026.

Based on Meriwether Wealth & Planning's 13F filing for Q3 2026, filed 13 Oct 2026.